219 related articles for article (PubMed ID: 34385260)
1. Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.
Yoon JH; Johnson RE; Prakash L; Prakash S
Genes Dev; 2021 Sep; 35(17-18):1256-1270. PubMed ID: 34385260
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
[TBL] [Abstract][Full Text] [Related]
3. Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.
Yoon JH; Park J; Conde J; Wakamiya M; Prakash L; Prakash S
Genes Dev; 2015 Dec; 29(24):2588-602. PubMed ID: 26680302
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
Pustovalova Y; Magalhães MT; D'Souza S; Rizzo AA; Korza G; Walker GC; Korzhnev DM
Biochemistry; 2016 Apr; 55(13):2043-53. PubMed ID: 26982350
[TBL] [Abstract][Full Text] [Related]
5. Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.
Akagi J; Masutani C; Kataoka Y; Kan T; Ohashi E; Mori T; Ohmori H; Hanaoka F
DNA Repair (Amst); 2009 May; 8(5):585-99. PubMed ID: 19157994
[TBL] [Abstract][Full Text] [Related]
6. The DNA polymerase activity of Saccharomyces cerevisiae Rev1 is biologically significant.
Wiltrout ME; Walker GC
Genetics; 2011 Jan; 187(1):21-35. PubMed ID: 20980236
[TBL] [Abstract][Full Text] [Related]
7. Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.
Sail V; Rizzo AA; Chatterjee N; Dash RC; Ozen Z; Walker GC; Korzhnev DM; Hadden MK
ACS Chem Biol; 2017 Jul; 12(7):1903-1912. PubMed ID: 28541665
[TBL] [Abstract][Full Text] [Related]
8. DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.
Sharma S; Shah NA; Joiner AM; Roberts KH; Canman CE
Mol Pharmacol; 2012 Jun; 81(6):778-87. PubMed ID: 22387291
[TBL] [Abstract][Full Text] [Related]
9. Genetic control of predominantly error-free replication through an acrolein-derived minor-groove DNA adduct.
Yoon JH; Hodge RP; Hackfeld LC; Park J; Roy Choudhury J; Prakash S; Prakash L
J Biol Chem; 2018 Feb; 293(8):2949-2958. PubMed ID: 29330301
[TBL] [Abstract][Full Text] [Related]
10. REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.
Chatterjee N; Whitman MA; Harris CA; Min SM; Jonas O; Lien EC; Luengo A; Vander Heiden MG; Hong J; Zhou P; Hemann MT; Walker GC
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28918-28921. PubMed ID: 33168727
[TBL] [Abstract][Full Text] [Related]
11. The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.
Hashimoto K; Cho Y; Yang IY; Akagi J; Ohashi E; Tateishi S; de Wind N; Hanaoka F; Ohmori H; Moriya M
J Biol Chem; 2012 Mar; 287(12):9613-22. PubMed ID: 22303021
[TBL] [Abstract][Full Text] [Related]
12. Sequential assembly of translesion DNA polymerases at UV-induced DNA damage sites.
Andersen PL; Xu F; Ziola B; McGregor WG; Xiao W
Mol Biol Cell; 2011 Jul; 22(13):2373-83. PubMed ID: 21551069
[TBL] [Abstract][Full Text] [Related]
13. NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase η.
Pozhidaeva A; Pustovalova Y; D'Souza S; Bezsonova I; Walker GC; Korzhnev DM
Biochemistry; 2012 Jul; 51(27):5506-20. PubMed ID: 22691049
[TBL] [Abstract][Full Text] [Related]
14. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
Pustovalova Y; Maciejewski MW; Korzhnev DM
J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
[TBL] [Abstract][Full Text] [Related]
15. Translesion synthesis mechanisms depend on the nature of DNA damage in UV-irradiated human cells.
Quinet A; Martins DJ; Vessoni AT; Biard D; Sarasin A; Stary A; Menck CF
Nucleic Acids Res; 2016 Jul; 44(12):5717-31. PubMed ID: 27095204
[TBL] [Abstract][Full Text] [Related]
16. The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.
Rizzo AA; Korzhnev DM
Enzymes; 2019; 45():139-181. PubMed ID: 31627876
[TBL] [Abstract][Full Text] [Related]
17. Distinct requirements for budding yeast Rev1 and Polη in translesion DNA synthesis across different types of DNA damage.
Wang Z; Xiao W
Curr Genet; 2020 Oct; 66(5):1019-1028. PubMed ID: 32623695
[TBL] [Abstract][Full Text] [Related]
18. WRN exonuclease imparts high fidelity on translesion synthesis by Y family DNA polymerases.
Yoon JH; Sellamuthu K; Prakash L; Prakash S
Genes Dev; 2024 Apr; 38(5-6):213-232. PubMed ID: 38503516
[TBL] [Abstract][Full Text] [Related]
19. Translesion synthesis DNA polymerases promote error-free replication through the minor-groove DNA adduct 3-deaza-3-methyladenine.
Yoon JH; Roy Choudhury J; Park J; Prakash S; Prakash L
J Biol Chem; 2017 Nov; 292(45):18682-18688. PubMed ID: 28939775
[TBL] [Abstract][Full Text] [Related]
20. The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.
Sharma NM; Kochenova OV; Shcherbakova PV
J Biol Chem; 2011 Sep; 286(38):33557-66. PubMed ID: 21799021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
